Biotage Open New Manufacturing Plant in South Wales
Biotage (Uppsala, Sweden) has opened a new manufacturing unit in Ystrad Mynach, South Wales, with the support of the Welsh Government. As part of the expansion at the South Wales site, an instrument-manufacturing unit has been moved from Boston, USA. Thanks to a grant from the Welsh Government, the company secured the use of a 825 square metre facility near to their existing premises and converted the area into a manufacturing line and offices.
Image: Mr. Ove Mattson, Chairman of the Board.
Biotage (Uppsala, Sweden) has opened a new manufacturing unit in Ystrad Mynach, South Wales, with the support of the Welsh Government. As part of the expansion at the South Wales site, an instrument-manufacturing unit has been moved from Boston, USA. Thanks to a grant from the Welsh Government, the company secured the use of a 825 square metre facility near to their existing premises and converted the area into a manufacturing line and offices.
Economy Minister Edwina Hart said: “I am delighted the Welsh Government has been able to support this very important inward investment project which helps consolidate Biotage’s presence in Wales. Life sciences are one of our key economic sectors with potential for high growth which makes this new investment particularly welcome and I wish them every success for the future.”
Chris Williams, UK Managing Director, said: “This has been a hugely successful project and I congratulate all the staff involved. I should stress that there is no complacency and we will be focused on continuous process improvement.”
For more information please visit: www.biotage.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
